Sharps injuries
This article was originally published in The Gray Sheet
Executive Summary
Comprehensive 1web-based list of needlestick-safety devices, categorizing products by primary or secondary prevention against injuries, is launched by the National Alliance for the Primary Prevention of Sharps Injuries (NAPPSI). The site's organization differs from a previous list, created by the Exposure Prevention Information Network at the International Healthcare Worker Safety Center of the University of Virginia, which categorized devices by their medical application...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.